GLT1D1 and lymphoma: We showed that GLT1D1 was significantly upregulated in incurable lymphoma (MCL) and in a subset of DLBCL patients with poor prognosis, suggesting that high expression of GLT1D1 may predict high risk of lymphoma relapse, likely due in part to immunosuppression.